Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.

Autor: Cherubini A; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Ostadreza M; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Jamialahmadi O; Department of Molecular and Clinical Medicine, Gothenburg University, Gothenburg, Sweden., Pelusi S; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Rrapaj E; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Casirati E; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Passignani G; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Norouziesfahani M; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Sinopoli E; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Baselli G; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Meda C; Department of Health Sciences, Università degli Studi di Milano, Milan, Italy., Dongiovanni P; Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Dondossola D; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.; General and Liver Transplant Surgery, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico and University of Milan, Centre of Preclinical Research, Milan, Italy., Youngson N; Foundation for Liver Research, The Roger Williams Institute of Hepatology, London, UK.; Faculty of Life Sciences and Medicine, King's College London, London, UK., Tourna A; Foundation for Liver Research, The Roger Williams Institute of Hepatology, London, UK., Chokshi S; Foundation for Liver Research, The Roger Williams Institute of Hepatology, London, UK.; Faculty of Life Sciences and Medicine, King's College London, London, UK., Bugianesi E; Department of Medical Sciences, Division of Gastroenterology, University of Turin, Turin, Italy., Della Torre S; Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy., Prati D; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Romeo S; Department of Molecular and Clinical Medicine, Gothenburg University, Gothenburg, Sweden.; Cardiology Department, Sahlgrenska Hospital, Gothenburg, Sweden.; Department of Medical and Surgical Science, Magna Græcia University, Catanzaro, Italy., Valenti L; Precision Medicine-Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. luca.valenti@unimi.it.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy. luca.valenti@unimi.it.

Publikováno v: Nature medicine [Nat Med] 2024 Apr; Vol. 30 (4), pp. 1212.

Validation of a targeted gene panel sequencing for the diagnosis of hereditary chronic liver diseases.

Autor: Ronzoni L; Biological Resource Centre, Precision Medicine Lab, Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy., Marini I; Biological Resource Centre, Precision Medicine Lab, Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy., Passignani G; Biological Resource Centre, Precision Medicine Lab, Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy., Malvestiti F; Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milano, Italy., Marchelli D; Biological Resource Centre, Precision Medicine Lab, Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy., Bianco C; Biological Resource Centre, Precision Medicine Lab, Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy., Pelusi S; Biological Resource Centre, Precision Medicine Lab, Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy., Prati D; Biological Resource Centre, Precision Medicine Lab, Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy., Valenti L; Biological Resource Centre, Precision Medicine Lab, Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy.; Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milano, Italy.

Publikováno v: Frontiers in genetics [Front Genet] 2023 Jun 14; Vol. 14, pp. 1137016. Date of Electronic Publication: 2023 Jun 14 (Print Publication: 2023).

Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancer.

Autor: Bari E; Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Piemonte, Italy., Ferrera F; Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genova, Liguria, Italy., Altosole T; Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genova, Liguria, Italy., Perteghella S; Department of Drug Sciences, University of Pavia, Pavia, Lombardia, Italy.; PharmaExceed S.r.l, Pavia, Lombardia, Italy., Mauri P; Institute for Biomedical Technologies, ITB CNR, Segrate, Lombardia, Italy., Rossi R; Institute for Biomedical Technologies, ITB CNR, Segrate, Lombardia, Italy., Passignani G; Institute for Biomedical Technologies, ITB CNR, Segrate, Lombardia, Italy., Mastracci L; Anatomic Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Liguria, Italy.; Department of Surgical and Integrated Diagnostic Sciences, University of Genoa, Genova, Liguria, Italy., Galati M; Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genova, Liguria, Italy., Astone GI; Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genova, Liguria, Italy., Mastrogiacomo M; Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genova, Liguria, Italy., Castagnola P; Biotherapy Unit, IRCCS Ospedale Policlinico San Martino, Genova, Liguria, Italy., Fenoglio D; Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genova, Liguria, Italy.; Biotherapy Unit, IRCCS Ospedale Policlinico San Martino, Genova, Liguria, Italy., Di Silvestre D; Institute for Biomedical Technologies, ITB CNR, Segrate, Lombardia, Italy., Torre ML; Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Piemonte, Italy.; PharmaExceed S.r.l, Pavia, Lombardia, Italy., Filaci G; Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genova, Liguria, Italy gfilaci@unige.it.; Biotherapy Unit, IRCCS Ospedale Policlinico San Martino, Genova, Liguria, Italy.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jan; Vol. 11 (1).

A functional interaction between hepatic estrogen receptor-α and PNPLA3 p.I148M inherited variant drives fatty liver disease susceptibility in women

Autor: Cherubini, A., Ostadreza, M., Jamialahmadi, O., Pelusi, S., Rrapaj, E., Casirati, E., Passignani, G., Baselli, G., Ronzoni, L., Dongiovanni, P., Prati, D., Romeo, S., Valenti, L.

Publikováno v: In Digestive and Liver Disease March 2023 55 Supplement 1:S13-S13

Microvesicles released from activated CD4 ⁺ T cells alter microvascular endothelial cell function.

Autor: Vdovenko D; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland., Balbi C; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.; Laboratory of Cellular and Molecular Cardiology, Istituto Cardiocentro Ticino-EOC, Lugano, Switzerland.; Laboratories for Translational Research-EOC, Bellinzona, Switzerland., Di Silvestre D; Proteomics and Metabolomic Lab, ITB-CNR, Segrate, Italy., Passignani G; Proteomics and Metabolomic Lab, ITB-CNR, Segrate, Italy., Puspitasari YM; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland., Zarak-Crnkovic M; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland., Mauri P; Proteomics and Metabolomic Lab, ITB-CNR, Segrate, Italy., Camici GG; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland., Lüscher TF; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.; Royal Brompton & Harefield Hospital, Imperial College, London, UK., Eriksson U; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.; Department of Medicine, GZO - Zurich Regional Health Center, Wetzikon, Switzerland., Vassalli G; Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.; Laboratory of Cellular and Molecular Cardiology, Istituto Cardiocentro Ticino-EOC, Lugano, Switzerland.; Laboratories for Translational Research-EOC, Bellinzona, Switzerland.; Department of Biomedicine, Università della Svizzera Italiana (USI), Lugano, Switzerland.

Publikováno v: European journal of clinical investigation [Eur J Clin Invest] 2022 Jun; Vol. 52 (6), pp. e13769. Date of Electronic Publication: 2022 Mar 31.